Mozos Ioana
Department of Functional Sciences, "Victor Babes" University of Medicine and Pharmacy, T. Vladimirescu Street 14, 300173 Timisoara, Romania.
Biomed Res Int. 2014;2014:509204. doi: 10.1155/2014/509204. Epub 2014 May 26.
Sudden cardiac death continues to be a major public health problem. Ventricular arrhythmia is a main cause of sudden cardiac death. The present review addresses the links between renal function tests, several laboratory markers, and ventricular arrhythmia risk in patients with renal disease, undergoing or not hemodialysis or renal transplant, focusing on recent clinical studies. Therapy of hypokalemia, hypocalcemia, and hypomagnesemia should be an emergency and performed simultaneously under electrocardiographic monitoring in patients with renal failure. Serum phosphates and iron, PTH level, renal function, hemoglobin and hematocrit, pH, inflammatory markers, proteinuria and microalbuminuria, and osmolarity should be monitored, besides standard 12-lead ECG, in order to prevent ventricular arrhythmia and sudden cardiac death.
心脏性猝死仍然是一个主要的公共卫生问题。室性心律失常是心脏性猝死的主要原因。本综述探讨了肾功能检查、几种实验室指标与肾病患者（无论是否接受血液透析或肾移植）室性心律失常风险之间的联系，重点关注近期的临床研究。对于肾衰竭患者，低钾血症、低钙血症和低镁血症的治疗应作为紧急情况，并在心电图监测下同时进行。除标准12导联心电图外，还应监测血清磷酸盐和铁、甲状旁腺激素水平、肾功能、血红蛋白和血细胞比容、pH值、炎症标志物、蛋白尿和微量白蛋白尿以及渗透压，以预防室性心律失常和心脏性猝死。
